Shanghai Junshi Biosciences, listed under stock code 01877 on the Hong Kong Stock Exchange, released its monthly return for 31 January 2026. The total registered share capital reached 1.03 billion RMB, comprising 260.30 million H shares and 766.39 million A shares, both unchanged from the previous month.

The monthly return shows no changes in the number of issued shares or treasury shares for either H shares or A shares compared with the previous month. The issuer confirmed compliance with regulatory public float requirements for its H shares. No warrants, convertibles, or other share issuance arrangements were recorded.

Under the H Share Option Incentive Scheme approved on 29 September 2025, 13.21 million H share options remained outstanding. For the A Share Option Incentive Scheme, also approved on 29 September 2025, 24.70 million A share options remained outstanding. There were no exercises of these options, and no new shares were issued or transferred from treasury shares during the month.